Head and neck surgery during the coronavirus-19 pandemic: The University of California San Francisco experience.
Head Neck
; 43(2): 622-629, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-886970
ABSTRACT
BACKGROUND:
Guidelines regarding head and neck surgical care have evolved during the coronavirus-19 (COVID-19) pandemic. Data on operative management have been limited.METHODS:
We compared two cohorts of patients undergoing head and neck or reconstructive surgery between March 16, 2019 and April 16, 2019 (pre-COVID-19) and March 16, 2020 and April 16, 2020 (COVID-19) at an academic center. Perioperative, intraoperative, and postoperative outcomes were recorded.RESULTS:
There were 63 operations during COVID-19 and 84 operations during pre-COVID-19. During COVID-19, a smaller proportion of patients had benign pathology (12% vs 20%, respectively) and underwent thyroid procedures (2% vs 23%) while a greater proportion of patients underwent microvascular reconstruction±ablation (24% vs 12%,). Operative times increased, especially among patients undergoing microvascular reconstruction±ablation (687 ± 112 vs 596 ± 91 minutes, P = .04). Complication rates and length of stay were similar.CONCLUSIONS:
During COVID-19, perioperative outcomes were similar, operative time increased, and there were no recorded transmissions to staff or patients. Continued surgical management of head and neck cancer patients can be provided safely.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Otorhinolaryngologic Surgical Procedures
/
Plastic Surgery Procedures
/
COVID-19
/
Head and Neck Neoplasms
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
North America
Language:
English
Journal:
Head Neck
Journal subject:
Neoplasms
Year:
2021
Document Type:
Article
Affiliation country:
Hed.26514
Similar
MEDLINE
...
LILACS
LIS